MeSH D002869 - chromosome aberrations
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D009154:Mutation
0 Companies
0 Drugs
Success rate
D002869:
Chromosome aberrations
0 Companies
0 Drugs
Success rate
D000072837:Chromothripsis
0 Companies
0 Drugs
Success rate
D000782:Aneuploidy
0 Companies
0 Drugs
Success rate
D007446:Chromosome inversion
0 Companies
0 Drugs
Success rate
D009630:Genetic nondisjunction
0 Companies
0 Drugs
Success rate
D011123:Polyploidy
0 Companies
0 Drugs
Success rate
D012303:Ring chromosomes
0 Companies
0 Drugs
Success rate
D012729:Sex chromosome aberrations
0 Companies
0 Drugs
Success rate
D014178:Genetic translocation
0 Companies
0 Drugs
Success rate
D018404:Isochromosomes
0 Companies
0 Drugs
Success rate
D019457:Chromosome breakage
0 Companies
0 Drugs
Success rate
D043171:Chromosomal instability
0 Companies
0 Drugs
Success rate
D048629:Chromosome-defective micronuclei
0 Companies
0 Drugs
Success rate
D058674:Chromosome duplication
0 Companies
0 Drugs
Success rate
D059786:Abnormal karyotype
0 Companies
0 Drugs
Success rate
D009030:Mosaicism
0 Companies
0 Drugs
Success rate
D024182:Uniparental disomy
0 Companies
0 Drugs
Success rate
D046528:Chimerism
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
0%0/0
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use